Smoking is the practice of inhaling or tasting of smoke released when a substance is burned. The most common substance used for smoking is tobacco while the cannabis and opium are also smoked often by people however less commonly. Most common smoking implement is cigarettes followed by pipes, bidis, hookahs, cigars and vaporizers. Smoking is considered as a serious threat to human health due to its risk associated with medical conditions such as heart diseases, pulmonary diseases, respiratory disorders, infertility, osteoporosis and cancer.
The primary cause for smoking is the gap between the lifestyles of different social classes. Curing of smoking related diseases is possible and because of intense health related concerns, primary health care providers are increasingly taking efforts for promoting cessation of smoking in patients. Prior to the initiation of smoking cessation therapy, important factors to be considered include patient’s willingness to opt for therapy, its medical history, previous experience with anti-smoking aids, and other patient characteristics such as contraindications, depression history and level of smoking. It is often recommended that pharmacologic therapy should be combined with appropriate behavioral counseling to the patient in order to enhance cessation rates in long term. Common anti-smoking aids include prescription drugs, over-the-counter products, nicotine replacement therapy, nicotine receptor partial agonist and antidepressant therapy along with counseling, encouragement and support or referral to quit smoking and programs for the same.
Drugs for smoking cessation are categorized as first line agents, second line agents and combination therapy. Several first line medications have been already approved by the FDA for individuals attempting to quit smoking while there are several other therapies which are recommended only if the patient is unable to quit smoking with mono-therapy. Currently, the number of prescriptions for nicotine replacement therapy and bupropion has been seen to reduce with a simultaneous increase in the number of prescriptions for varenicline.
The major reason for growth in the scope of this market is the increased number of smokers willing to curb smoking habit. The market is predicted to grow continuously due to the rising incidence and prevalence of smoking in developed and under-developed countries. Various innovations and formulations in pipeline along with the availability of new generic drugs and drug delivery technologies are also seen to be promising in the near future.
Smoking remains the main segment in list of cause for preventable diseases majorly in Americas followed by Europe. Developing countries such as India, China, Brazil and Sweden also show growth potential in the smoking cessation market. The demand for better anti-smoking aids in market is attributed to the need for drugs with minimal side effects and least scope for post-treatment relapse. The major market players for anti-smoking aids are Johnson & Johnson Limited, GlaxoSmithKline Pharmaceuticals Limited, Pfizer, Inc. and Novartis International AG.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments